OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabetes (T1D). Here, we assessed the risk of autoantibody spreading to the second-appearing autoantibody and further progression to clinical disease in the Environmental Determinants of Diabetes in the Young study.RESEARCH DESIGN AND METHODS: Eligible children with increased HLA-DR-DQ genetic risk for T1D were followed quarterly from age 3 months up to 15 years for development of a single first-appearing autoantibody (GAD antibody [GADA], insulin autoantibody [IAA], or IA2 autoantibody [IA-2A]) and subsequent development of a single second-appearing autoantibody and progression to T1D. Autoantibody positivity was defined as positivity for a specif...
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
Aims: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
AIMS/HYPOTHESIS: Islet autoantibody-positive children progress to type 1 diabetes at variable rates....
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabet...
OBJECTIVE The first-appearing b-cell autoantibody has been shown to influence risk of type 1 diabete...
AIMS/HYPOTHESIS: Young children who develop multiple autoantibodies (mAbs) are at very high risk for...
OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Her...
OBJECTIVE β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we ...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: While it is known that there is progression to diabetes in <10 years in 70% of childre...
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
AIMS: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
AIMS/HYPOTHESIS: Progression to type 1 diabetes in children and adolescents is not uniform. Based on...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
Aims/hypothesis Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes....
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
Aims: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
AIMS/HYPOTHESIS: Islet autoantibody-positive children progress to type 1 diabetes at variable rates....
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabet...
OBJECTIVE The first-appearing b-cell autoantibody has been shown to influence risk of type 1 diabete...
AIMS/HYPOTHESIS: Young children who develop multiple autoantibodies (mAbs) are at very high risk for...
OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Her...
OBJECTIVE β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we ...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
OBJECTIVE: While it is known that there is progression to diabetes in <10 years in 70% of childre...
AIMS/HYPOTHESIS: Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes...
AIMS: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
AIMS/HYPOTHESIS: Progression to type 1 diabetes in children and adolescents is not uniform. Based on...
OBJECTIVE: To distinguish among predictors of seroconversion, progression to multiple autoantibodies...
Aims/hypothesis Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes....
This paper seeks to determine whether factors related to autoimmunity risk remain significant after ...
Aims: The onset of clinical type 1 diabetes (T1D) is preceded by the occurrence of disease-specific ...
AIMS/HYPOTHESIS: Islet autoantibody-positive children progress to type 1 diabetes at variable rates....